Concurrent Treatment with Anti-DLL4 Enhances Antitumor and Proapoptotic Efficacy of a γ-Secretase Inhibitor in Gastric Cancer()()

The Notch signaling pathway has been identified as a therapeutic target for cancers. γ-Secretase inhibitors (GSIs) have been progressively recognized as potential anticancer drugs. The present study aimed to investigate the effects of anti-delta like legend 4 (anti-DLL4) treatment on the anticancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Muxing, Zhang, Yaoyi, Jin, Xiaoli, Chen, Guofeng, Huang, Yi, Wu, Dan, Li, Guogang, Shan, Jianzhen, Huang, Pintong, Chen, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002351/
https://www.ncbi.nlm.nih.gov/pubmed/29571073
http://dx.doi.org/10.1016/j.tranon.2018.02.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002351/
https://www.ncbi.nlm.nih.gov/pubmed/29571073
http://dx.doi.org/10.1016/j.tranon.2018.02.016

Ejemplares similares